Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

US representative Alexandria Thursday Ocasio-Cortez and Jan Shakovsky sent letters to two potential buyers of unstable genetic testing firm 23 OME Customer data privacy should be achieved in detail among any of them.

Letters signed by 20 Democratic members of Congress – which could read Here And HereIn letters in the letters, they ask the resenters and TTAM whether they will continue the option of withdrawing their data for customers to delete their data and withdraw their consent to use their data in medical studies. They also want to know whether the current policy of not sharing genetic data with law enforcement without any warrants will remain the current policy of ME, and whether the two entities are intended to actively inform the customers about sale and ME customers.

After a few years of fighting to earn a profit, 23 and May filed bankruptcy for the protection of bankruptcy and kept it for sale. After a short period of time, its CEO, AnnResignation. Wadiki failed to make the company a private, but his proposals were rejected by a special committee formed by 23 and ME’s board of directors.

In May, the biotech company, Razneron, announced that it was named after a successful bidder at a bankrupt auction, providing $ 256 million to achieve 23 OMEs. “We believe that we are interested in learning about 23 and their own DNA and to help them supply their mission to help them improve their personal health, while the resource of the society is further up to the use of the society to treat and prevent society with the society,” George Yankoploos, Cofown, and Chief Senkopolos, and Chief Senkopolos, Cofown. ” Company statement Last month.

However, after the auction closed, Wasiki kept a bid of his own – the newly formed non -profit, $ 305 million more via TTAM Research Institute. The offer encouraged a federal judge to open the sale process again and now both the Razneron and TTAM have the opportunity to give the final bid.

Established in 2006, 23 and my DNA test kit played a leading role in the field of personal genomics, which allow customers to learn about certain treatment risks after submitting their predecessors, family connections and spit samples. Despite selling more than 12 million of its DNA test kit, the company never gained profitability and did not struggle to diversify its revenue flow after approaching the public in 2021. In another push to the company, a major information violation in 2021 opens the personal information of millions of customers, Including a leak It targets users with the Chinese and Ashkani Jewish Heritage Taha.

The new owner of 23ndme will achieve a wide range of its genetic data, raising questions about how the data will be used. Under the current policy of 23ndme, customers may choose to make their genetic data and other personal information available for treatment research. They also have The option to erase all their data And instruction to destroy 23 and their saliva samples. Members of the Congress who sent the letter on Thursday are seeking clarification from Rizneron and Wajiki about whether they are planning to continue these practices.

Law enforcement and immigration authorities are also concerned about sharing genetic data and sharing genetic data about the possibility of genetic and other personal data to be trained for training. They are currently asking to publish a full list of all third parties who currently have access to 23 and ME Data, and the steps that both entities will take to ensure the transparency of third party access in the future. 23 and had previously had many years of research cooperation with Pharma giant Glaxo Smithlin.

Representatives are asking to respond to the Razneron and TTAM by June 26.

Wasiki and 23 and OME’s interim CEO Joe Salesvez, testified at a time House Overseas Committee Anxiety on privacy and national protection this week listened to 23 and surround ME’s sales. During the hearing, Salesavage told lawmakers that since filed for bankruptcy in March, 1.5 million people or about 5 percent of its customers have been asked to remove their genetic data company servers.

This week, more than two dozen states and Colombia districts have filed a case against 23andme, arguing that the company cannot auction the highly sensitive personal genetic information of 15 million customers without their consent or knowledge.